In detail, the anti-lymphoma activity of CAR.CD19-T cells was tested in long-term co-culture assays with CD19+ lymphoma Daudi (Fig. 1a) and Raji (Supplementary Fig. 1a) cell lines, either in the absence or in the presence of the anti-IFNγ mAb emapalumab. The gene discussed is CD19; the disease is lymphoma.